跳至主要内容
临床试验/NCT01303107
NCT01303107撤回3 期

A Non-Inferiority Phase 3 Comparative Study Between a Heavy Levobupivacaine in 50% Enantiomeric Excess (Bupivacaine S75:R25) and Heavy Racemic Bupivacaine for Cesarean Operation

Cristália Produtos Químicos Farmacêuticos Ltda.2 个研究点 分布在 1 个国家开始时间: 2011年2月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
试验地点
2
主要终点
latency of sensitive block at T6

研究概览

简要总结

The purpose of this study is to determine if the mixture of enantiomers of bupivacaine (bupivacaine S75:R25) dos not represent inferiority efficacy and safety compare to the racemic mixture of enantiomers of bupivacaine (bupivacaine S50:R50).

详细描述

The enantiomeric mixture of bupivacaine S75:R25 (75% levobupivacaine and 25% bupivacaine) was develop to be a safety regional anesthetic in substitution to racemic bupivacaine (S50:R50).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • parturients at term
  • ASA (American Society of Anesthesiologists) I or ASA II
  • elective cesarean section with low risk labor
  • pre-natal follow-up
  • patient consent

排除标准

  • relative or absolute contraindications for spinal anesthesia
  • history of hypersensitivity to the local anesthetics
  • use of opioids during labor
  • labor lasting more than 12 hours or less than 1 hour
  • complications of pregnancy such as placenta previa, pre-eclampsia or eclampsia; maternal-fetal malnutrition;important accidents during pregnancy.
  • spinal lesions, peripheral neuropathies or any other neurologic disorders that lead to changes of sensitivity and/or motricity
  • decompensated diabetes or hypertension
  • history of alcohol and/or drug abuse
  • cardiopathies, especially myocardiopathies and valvulopathies; important cognitive changes
  • changes in safety exams
  • twin pregnancy;
  • signs of intrauterine distress, and abnormalities of fetal vitality, prematurity

研究组 & 干预措施

bupivacaine S50:R50

Active Comparator

3 ml subarachnoid block

干预措施: Bupivacaine (Drug)

bupivacaine S75:R25

Experimental

3 ml for subarachnoid block

干预措施: Bupivacaine (Drug)

结局指标

主要结局

latency of sensitive block at T6

时间窗: loss of pain in T6

The anesthesiologist will evaluate the loss of pain to pin-prick in T10.

次要结局

  • duration of the anesthesia(recovery of the sensibility)
  • Degree of motor block(End of motor block)
  • maximal level of the sensitive blockade(last level of sensitive blockade)
  • Maternal cardiocirculatory and respiratory parameters(During the study)
  • Parturients ambulation(regression of the motor blockade)
  • Visceral pain(suture of the peritoneum)
  • Neonatal repercussions(birth of the neonatal)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验